RESEARCH PAPER
Decade-long trends in prostate cancer incidence and mortality in Poland, 1999–2012
 
More details
Hide details
1
Department of Uro-Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
2
Center for Prostate Disease Research, Rockville, MD, USA
3
Department. of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
CORRESPONDING AUTHOR
Jennifer Cullen   

Center for Prostate Disease Research, 1530 East Jefferson Street, Rockville, MD, 20852, USA.
Submission date: 2017-02-22
Acceptance date: 2017-05-02
Online publication date: 2018-02-23
Publication date: 2019-11-16
 
Pol. Ann. Med. 2018;25(1):56–61
 
KEYWORDS
ACKNOWLEDGEMENTS
We would like to thank George W. Handy, Activity for Innovation and Economic Growth, for forging the collaboration between this team of researchers from the United States and Poland, and for his support throughout the course of this project.
CONFLICT OF INTEREST
None.
 
REFERENCES (19)
1.
Center MM, Jemal A, Lortet-Tieulent J, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;61(6):1079–1092. https://doi.org/10.1016/j.euru....
 
2.
Wojciechowska U, Didkowska J, Zatonski W. Cancer in Poland in 2012. Warsaw: Polish National Cancer Registry, Department of Epidemiology and Cancer Prevention; 2014.
 
3.
Arnold M, Karim-Kos HE, Coebergh JW, et al. Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory. Eur J Cancer. 2015;51(9):1164–1187. https://doi.org/10.1016/j.ejca....
 
4.
Capocaccia R, Colonna M, Corazziari I, et al. Measuring cancer prevalence in Europe: the EUROPREVAL project. Ann Oncol. 2002;13(6):831–839. https://doi.org/10.1093/annonc....
 
5.
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–1403. https://doi.org/10.1016/j.ejca....
 
6.
De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study. Lancet Oncol. 2014;15(1):23–34. https://doi.org/10.1016/S1470-....
 
7.
Vrdoljak E, Wojtukiewicz MZ, Pienkowski T, et al. Cancer epidemiology in Central, South and Eastern European countries. Croat Med J. 2011;52(4):478–487. https://doi.org/10.3325/cmj.20....
 
8.
Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385(9972):977–1010. https://doi.org/10.1016/S0140-....
 
9.
Bosetti C, Bertuccio P, Chatenoud L, Negri E, La Vecchia C, Levi F. Trends in mortality from urologic cancers in Europe, 1970-2008. Eur Urol. 2011;60(1):1–15. https://doi.org/10.1016/j.euru....
 
10.
Doll R, Payne P, Waterhouse JAH, eds. Cancer Incidence in Five Continents. Vol. 1. Geneva: Union Internationale Contre le Cancer; 1966. https://doi.org/10.1007/978-3-....
 
11.
Segi M. Cancer Mortality for Selected Sites in 24 Countries (1950–57). Sendai, Japan: Department of Public Health, Tohoku University of Medicine; 1960.
 
12.
Kleinbaum DG, Kupper LL, Muller KE. Applied Regression Analysis and Other Multivariable Methods. 2nd Ed. Boston: PWS–Kent; 1988.
 
13.
Mottet N, Bastian PJ, Bellmunt J, van den Bergh RCN, Bolla M, van Casteren NJ, et al. Guidelines on Prostate Cancer. Uroweb: European Association of Urology; 2014.
 
14.
Leitzmann MF, Rohrmann S. Risk factors for the onset of prostatic cancer: age, location, and behavioral correlates. Clin Epidemiol. 2012;4:1–11. https://doi.org/10.2147/CLEP.S....
 
15.
Ministry of Health. Establishing and implementation of an early detection program for urogenital cancer among working men aged 45 years and over (45+), focused on preventing professional deactivation (concerning specifically men employed in professions related to high urogenital cancer risk). https://www.google.pl/url?sa=t.... Accessed: 16.02.2018 [in Polish].
 
16.
Fogleman AJ, Mueller GS, Jenkins WD. Does where you live play an important role in cancer incidence in the U.S.? Am J Cancer Res. 2015;5(7):2314–2319.
 
17.
Di Francesco S, Tenaglia RL. Obesity, diabetes and aggressive prostate cancer hormone-naive at initial diagnosis. Cent European J Urol. 2014;66(4):423–427.
 
18.
Neppl-Huber C, Zappa M, Coebergh JW, et al. Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths. Ann Oncol. 2012;23(5):1325–1334. https://doi.org/10.1093/annonc....
 
19.
Didkowska J, Wojciechowska U, Zatonski W. Prediction of cancer incidence and mortality in Poland up to the year 2025. Warszawa: Centrum Onkologii. Instytut M. Skłodowskiej-Curie; 2009.